Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Clinical trial NCT06912763 · RECRUITING
Trial details
- NCT number
- NCT06912763
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-08
- Primary completion
- 2030-07-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.